REVIEW QUESTIONS GERO AND
GI
Q1
• MATCH THE FOLLOWING AGE RELATED
CHANGES IN THE SENSES WITH THE PROBLEM
REPORTED BY THE OLDER ADULT
• 1. DIFFICULTY WITH APPRECIATING THE
CONTENT OF CONVERSATION IN A NOISY
ENVIRONMENT
• 2. DECLINE IN THE SENSE OF SMELL
• 3. PAINLESS VISION CHANGE THAT INCLUDES
CENTRAL VISION DISTORTION
• 4. RESULTS IN NEAR VISION BLURRINESS
• 5. CAN RESULT IN PERIPHERAL VISION LOSS
• A. HYPOSMIA
• B. PRESBYCUSIS
• C. PRESBYOPIA
• D. AGE-RELATED MACULOPATHY
• E. CHRONIC GLAUCOMA
A1
• MATCH THE FOLLOWING AGE RELATED
CHANGES IN THE SENSES WITH THE PROBLEM
REPORTED BY THE OLDER ADULT
• 1. DIFFICULTY WITH APPRECIATING THE
CONTENT OF CONVERSATION IN A NOISY
ENVIRONMENT B
• 2. DECLINE IN THE SENSE OF SMELL A
• 3. PAINLESS VISION CHANGE THAT INCLUDES
CENTRAL VISION DISTORTION D
• 4. RESULTS IN NEAR VISION BLURRINESS C
• 5. CAN RESULT IN PERIPHERAL VISION LOSS E
• A. HYPOSMIA
• B. PRESBYCUSIS
• C. PRESBYOPIA
• D. AGE-RELATED MACULOPATHY
• E. CHRONIC GLAUCOMA
Q2
• ALL OF THE FOLLOWING ARE CONSISTENT WITH NORMAL AGE-RELATED VISION CHANGES:
CHECK ALL THAT APPLY.
• GRADUAL CHANGE IN PERIPHERAL VISION
• INCREASING SENSITIVITY TO GLARE
• WASHING OUT OF COLORS
• A NEED FOR DECREASED ILLUMINATION
• A NEED FOR INCREASED ILLUMINATION
• DECREASED SENSITIVITY TO GLARE
A2
• GRADUAL CHANGE IN PERIPHERAL VISION
• INCREASING SENSITIVITY TO GLARE
• WASHING OUT OF COLORS
• A NEED FOR DECREASED ILLUMINATION
• A NEED FOR INCREASED ILLUMINATION
• DECREASED SENSITIVITY TO GLARE
Q3
• A RISK FACTOR FOR PRIMARY OPEN-ANGLE GLAUCOMA IS
• POSTURAL HYPOTENSION
• AGE MORE THAN 40 YEARS
• HISTORY OF FUNGAL CONJUNCTIVITIS
• WHITE RACE
A3
• A RISK FACTOR FOR PRIMARY OPEN-ANGLE GLAUCOMA IS
• POSTURAL HYPOTENSION
• AGE MORE THAN 40 YEARS
• HISTORY OF FUNGAL CONJUNCTIVITIS
• WHITE RACE
Q4
• AGE RELATED CHANGES IN AN ELDERLY ADULT INCLUDE ALL OF THE FOLLOWING EXCEPT:
• TOTAL BODY WATER DECREASES BY 10-15% BETWEEN AGES 20 AND 80 YEARS
• BODY WEIGHT AS FAT INCREASES FROM 18-36% IN MEN AND FROM 33-45% IN WOMEN
• AN INCREASE IN SERUM ALBUMIN
• AN INCREASE IN GASTRIC PH
A4
• AGE RELATED CHANGES IN AN ELDERLY ADULT INCLUDE ALL OF THE FOLLOWING EXCEPT:
• TOTAL BODY WATER DECREASES BY 10-15% BETWEEN AGES 20 AND 80 YEARS
• BODY WEIGHT AS FAT INCREASES FROM 18-36% IN MEN AND FROM 33-45% IN WOMEN
• AN INCREASE IN SERUM ALBUMIN
• AN INCREASE IN GASTRIC PH
Q5
• AGE RELATED RENAL CHANGES IN OLDER ADULTS POTENTIALLY INCLUDE ALL OF THE
FOLLOWING: CHECK ALL THAT APPLY
• DECREASED GFR
• INCREASED RENAL MASS TO COMPENSATE FOR DECREASED FUNCTION
• AN INCREASED GFR
• LOSS OF FUNCTIONAL NEPHRONS
• INCREASED RENAL BLOOD FLOW
• DECREASED RENAL BLOOD FLOW
A5
• AGE RELATED RENAL CHANGES IN OLDER ADULTS POTENTIALLY INCLUDE ALL OF THE
FOLLOWING: CHECK ALL THAT APPLY
• DECREASED GFR
• INCREASED RENAL MASS TO COMPENSATE FOR DECREASED FUNCTION
• AN INCREASED GFR
• LOSS OF FUNCTIONAL NEPHRONS
• INCREASED RENAL BLOOD FLOW
• DECREASED RENAL BLOOD FLOW
Q6
• THE USE OF WHICH OF THE FOLLOWING MEDICATIONS IS ASSOCIATED WITH THE LEAST RISK
OF POSTURAL HYPOTENSION IN THE OLDER ADULT?
• NIFEDIPINE
• FUROSEMIDE
• CLONIDINE
• LISINOPRIL
A6
• THE USE OF WHICH OF THE FOLLOWING MEDICATIONS IS ASSOCIATED WITH THE LEAST RISK
OF POSTURAL HYPOTENSION IN THE OLDER ADULT?
• NIFEDIPINE
• FUROSEMIDE
• CLONIDINE
• LISINOPRIL
Q7
• FALL RISK IN AN OLDER ADULT IS DECREASED WITH THE USE OF WHICH OF THE FOLLOWING
FOOTWEAR?
• SANDAL
• JOGGING SHOE
• SLIPPER
• SEMIRIGID SOLED SHOE
A7
• FALL RISK IN AN OLDER ADULT IS DECREASED WITH THE USE OF WHICH OF THE FOLLOWING
FOOTWEAR?
• SANDAL
• JOGGING SHOE
• SLIPPER
• SEMIRIGID SOLED SHOE
Q8
• WHICH OF THE FOLLOWING IS NOT PART OF THE “GET UP AND GO” CRITERIA WHEN
EVALUATING GAIT AND BALANCE FOR A 72 YEAR OLD WOMAN WHO NORMALLY USES A
WALKER?
• RISING FROM A STRAIGHT-BACKED CHAIR
• WALKING 10 FEET WITHOUT THE USE OF A WALKING AID
• TURNING AROUND AFTER WALKING 10 FEET
• RETURNING TO THE CHAIR AND SITTING DOWN
A8
• WHICH OF THE FOLLOWING IS NOT PART OF THE “GET UP AND GO” CRITERIA WHEN
EVALUATING GAIT AND BALANCE FOR A 72 YEAR OLD WOMAN WHO NORMALLY USES A
WALKER?
• RISING FROM A STRAIGHT-BACKED CHAIR
• WALKING 10 FEET WITHOUT THE USE OF A WALKING AID
• TURNING AROUND AFTER WALKING 10 FEET
• RETURNING TO THE CHAIR AND SITTING DOWN
Q9
• THE DIAGNOSIS OF ____ SHOULD BE CONSIDERED IN AN OLDER ADULT WITH NEW-ONSET
URINARY INCONTINENCE COUPLED WITH AN ACUTE CHANGE IN MENTAL STATUS.
• DEMENTIA
• SPINAL CORD COMPRESSION
• BLADDER STONE
• DELIRIUM
A9
• THE DIAGNOSIS OF ____ SHOULD BE CONSIDERED IN AN OLDER ADULT WITH NEW-ONSET
URINARY INCONTINENCE COUPLED WITH AN ACUTE CHANGE IN MENTAL STATUS.
• DEMENTIA
• SPINAL CORD COMPRESSION
• BLADDER STONE
• DELIRIUM
Q10
• WHICH OF THE FOLLOWING IS A TRUE STATEMENT WITH REGARD TO DISEASE PRESENTATION
IN OLDER ADULTS?
• NORMAL AGE-RELATED CHANGES DO NOT ALTER THE WAY AN ILLNESS PRESENTS
• DISEASES IN THE ELDERLY ARE USUALLY MORE DIFFICULT TO TREAT BECAUSE THE PRESENT AT LATER
STAGES
• DISEASE USUALLY PRESENT AT EARLIER STAGES AS A RESULT OF IMPAIRED COMPENSATORY SYSTEMS
• A MILD DECLINE IN MEMORY AND INFORMATION PROCESSING IS NOT A NORMAL AGE-RELATED
CHANGE
A10
• WHICH OF THE FOLLOWING IS A TRUE STATEMENT WITH REGARD TO DISEASE PRESENTATION
IN OLDER ADULTS?
• NORMAL AGE-RELATED CHANGES DO NOT ALTER THE WAY AN ILLNESS PRESENTS
• DISEASES IN THE ELDERLY ARE USUALLY MORE DIFFICULT TO TREAT BECAUSE THE PRESENT AT LATER
STAGES
• USUALLY PRESENT AT EARLIER STAGES AS A RESULT OF IMPAIRED COMPENSATORY SYSTEMS
• DISEASE A MILD DECLINE IN MEMORY AND INFORMATION PROCESSING IS NOT A NORMAL AGERELATED CHANGE
Q11
• IN OLDER ADULTS, HEART FAILURE CAN BE PRECIPITATED BY:
• MILD HYPOTHYROIDISM
• HYPERPARATHYROIDISM
• MILD HYPERKALEMIA
• MILD HYPONATREMIA
A11
• IN OLDER ADULTS, HEART FAILURE CAN BE PRECIPITATED BY:
• MILD HYPOTHYROIDISM
• HYPERPARATHYROIDISM
• MILD HYPERKALEMIA
• MILD HYPONATREMIA
Q12
• WHEN MANAGING DEMENTIA, CHOLINESTERASE INHIBITORS OFFER THE GREATEST BENEFIT:
• FOR PREVENTION OF ALZHEIMER’S-TYPE DEMENTIA
• IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT
• IN PATIENTS WITH MILD TO MODERATE AD
• IN PATIENTS WITH SEVERE AD
A12
• WHEN MANAGING DEMENTIA, CHOLINESTERASE INHIBITORS OFFER THE GREATEST BENEFIT:
• FOR PREVENTION OF ALZHEIMER’S-TYPE DEMENTIA
• IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT
• IN PATIENTS WITH MILD TO MODERATE AD
• IN PATIENTS WITH SEVERE AD
Q13
• THE USE OF ANTIPSYCHOTIC MEDICATIONS IS OLDER ADULTS IS ASSOCIATED WITH AN
INCREASED RISK FOR:
• STROKE AND CV EVENTS
• HYPOGLYCEMIA
• DELIRIUM
• HYPERTENSION
A13
• THE USE OF ANTIPSYCHOTIC MEDICATIONS IS OLDER ADULTS IS ASSOCIATED WITH AN
INCREASED RISK FOR:
• STROKE AND CV EVENTS
• HYPOGLYCEMIA
• DELIRIUM
• HYPERTENSION
Q14
• THE NMDA RECEPTOR ANTAGONIST MEMANTINE WORKS VIA:
• SLOWING THE DEATH OF NEURONS IN THE BRAIN
• CREATING AN ENVIRONMENT THAT ALLOWS FOR STORAGE AND RETRIEVAL OF INFORMATION
• PROMOTING MORE RAPID TRANSDUCTION OF NERVE SIGNALS
• A LARGELY UNKNOWN MECHANISM
A14
• THE NMDA RECEPTOR ANTAGONIST MEMANTINE WORKS VIA:
• SLOWING THE DEATH OF NEURONS IN THE BRAIN
• CREATING AN ENVIRONMENT THAT ALLOWS FOR STORAGE AND RETRIEVAL OF INFORMATION
• PROMOTING MORE RAPID TRANSDUCTION OF NERVE SIGNALS
• A LARGELY UNKNOWN MECHANISM
Q15
• IDENTIFY THE FOLLOWING AS MOST LIKELY
ASSOCIATED WITH EITHER DELIRIUM OR DEMENTIA
• DEMENTIA
• 1. INSIDIOUS ONSET OVER MONTHS TO YEARS
• DELIRIUM
• 2. ACUTE ONSET OF CHANGE IN MENTAL STATUS
• DELIRIUM
• 3. ASSOCIATED WITH USE OF MEDICATIONS WITH
SYSTEMIC ANTICHOLINERGIC EFFECT
• DELIRIUM
• 4. MENTAL STATUS POTENTIALLY RETURNS TO PREILLNESS BASELINE
• DEMENTIA
• 5. NO PERCEPTUAL DISTURBANCES (I.E
.HALLUCINATIONS) UNTIL LATER DISEASE
Q16
• WHICH OF THE FOLLOWING SUPPLEMENTS IS USED TO POTENTIALLY SLOW COGNITIVE
DECLINE IN AD?
• VITAMIN B12
• VITAMIN E
• GINKGO BILOBA
• ST. JOHN’S WART
A16
• WHICH OF THE FOLLOWING SUPPLEMENTS IS USED TO POTENTIALLY SLOW COGNITIVE
DECLINE IN AD?
• VITAMIN B12
• VITAMIN E
• GINKGO BILOBA
• ST. JOHN’S WART
Q17
• THE NP IS ADVISING A 34 YEAR OLD WOMAN ABOUT THE BENEFITS OF A HIGH FIBER DIET.
WHICH OF THE FOLLOWING FOODS PROVIDES THE HIGHEST FIBER CONTENT?
• BANANA
• 1 CUP COOKED OATMEAL
• ½ CUP BROWN RICE
• A MEDIUM SIZED BLUEBERRY MUFFIN
A17
• THE NP IS ADVISING A 34 YEAR OLD WOMAN ABOUT THE BENEFITS OF A HIGH FIBER DIET.
WHICH OF THE FOLLOWING FOODS PROVIDES THE HIGHEST FIBER CONTENT?
• BANANA
• 1 CUP COOKED OATMEAL
• ½ CUP BROWN RICE
• A MEDIUM SIZED BLUEBERRY MUFFIN
Q18
• A 26 YEAR OLD MAN PRESENTS WITH ACUTE ABDOMINAL PAIN. AS PART OF THE EVALUATION
FOR ACUTE APPENDICITIS, YOU ORDER A WHITE BLOOD CELL COUNT WITH DIFFERENTIAL AND
ANTICIPATE THE FOLLOWING RESULTS:
• TOTAL WBCS, 4500 MM; NEUTROPHILS, 35%; BANDS 2%; LYMPHOCYTES 45%
• TOTAL WBCS 14,000 MM; NEUTROPHILS, 55%; BANDS, 3%; LYMPHOCYTES, 38%
• TOTAL WBCS, 16,000 MM; NEUTROPHILS, 66%; BANDS 8%; LYMPHOCYTES, 22%
• TOTAL WBCS, 18,100 MM; NEUTROPHILS, 55%; BANDS 3%; LYMPHOCYTES, 28%
A18
• A 26 YEAR OLD MAN PRESENTS WITH ACUTE ABDOMINAL PAIN. AS PART OF THE EVALUATION
FOR ACUTE APPENDICITIS, YOU ORDER A WHITE BLOOD CELL COUNT WITH DIFFERENTIAL AND
ANTICIPATE THE FOLLOWING RESULTS:
• TOTAL WBCS, 4500 MM; NEUTROPHILS, 35%; BANDS 2%; LYMPHOCYTES 45%
• TOTAL WBCS 14,000 MM; NEUTROPHILS, 55%; BANDS, 3%; LYMPHOCYTES, 38%
• TOTAL WBCS, 16,000 MM; NEUTROPHILS, 66%; BANDS 8%; LYMPHOCYTES, 22%
• TOTAL WBCS, 18,100 MM; NEUTROPHILS, 55%; BANDS 3%; LYMPHOCYTES, 28%
Q19
• WHICH OF THE FOLLOWING IS USUALLY NOT SEEN IN THE DIAGNOSIS OF ACUTE
CHOLECYSTITIS?
• ELEVATED SERUM CREATININE
• INCREASED ALKALINE PHOSPHATASE LEVEL
• LEUKOCYTOSIS
• ELEVATED ALT LEVEL
A19
• WHICH OF THE FOLLOWING IS USUALLY NOT SEEN IN THE DIAGNOSIS OF ACUTE
CHOLECYSTITIS?
• ELEVATED SERUM CREATININE
• INCREASED ALKALINE PHOSPHATASE LEVEL
• LEUKOCYTOSIS
• ELEVATED ALT LEVEL
Q20
• WHICH OF THE FOLLOWING IS LIKELY TO BE NOTED IN A PERSON WITH COLORECTAL
CANCER?
• GROSS RECTAL BLEEDING
• WEIGHT LOSS
• FEW SYMPTOMS
• NAUSEA AND VOMITING
A20
• WHICH OF THE FOLLOWING IS LIKELY TO BE NOTED IN A PERSON WITH COLORECTAL
CANCER?
• GROSS RECTAL BLEEDING
• WEIGHT LOSS
• FEW SYMPTOMS
• NAUSEA AND VOMITING
Q21
• A 56 YEAR OLD FEMALE IS DIAGNOSED WITH MILD DIVERTICULITIS. IN ADDITION TO
COUNSELING HER ABOUT FLUID INTAKE AND ADEQUATE REST, YOU RECOMMEND
ANTIMICROBIAL TX WITH:
• AMOXICILLIN WITH CLARITHROMYCIN
• LINEZOLID WITH DAPTOMYCIN
• CIPROFLOXACIN WITH METRONIDAZOLE
• NITROFURANTOIN WITH DOXYCYCLINE
A 21
• A 56 YEAR OLD FEMALE IS DIAGNOSED WITH MILD DIVERTICULITIS. IN ADDITION TO
COUNSELING HER ABOUT FLUID INTAKE AND ADEQUATE REST, YOU RECOMMEND
ANTIMICROBIAL TX WITH:
• AMOXICILLIN WITH CLARITHROMYCIN
• LINEZOLID WITH DAPTOMYCIN
• CIPROFLOXACIN WITH METRONIDAZOLE
• NITROFURANTOIN WITH DOXYCYCLINE
Q22
• A 24 YEAR OLD MALE PRESENTS WITH A E MONTH HISTORY OF UPPER ABDOMINAL. HE
DESCRIBES IT AN AN INTERMITTENT, CENTRALLY LOCATED “BURNING” FEELING IN HIS UPPER
ABDOMEN, MOST OFTEN OCCURRING 2-3 HOURS AFTER MEALS. HIS PRESENTATION IS LIKELY:
• ACUTE GASTRITIS
• GASTRIC ULCER
• DUODENAL ULCER
• CHOLECYSTITIS
A22
• A 24 YEAR OLD MALE PRESENTS WITH A E MONTH HISTORY OF UPPER ABDOMINAL. HE
DESCRIBES IT AN AN INTERMITTENT, CENTRALLY LOCATED “BURNING” FEELING IN HIS UPPER
ABDOMEN, MOST OFTEN OCCURRING 2-3 HOURS AFTER MEALS. HIS PRESENTATION IS LIKELY:
• ACUTE GASTRITIS
• GASTRIC ULCER
• DUODENAL ULCER
• CHOLECYSTITIS
Q23
• A 64 YEAR OLD FEMALE PRESENTS WITH A 3 MONTH HISTORY OF UPPER ABDOMINAL PAIN. SHE
DESCRIBES THE DISCOMFORT AS AN INTERMITTENT, CENTRALLY LOCATED “BURNING” FEELING IN
THE UPPER ABDOMEN, MOST OFTEN WITH MEALS AND OFTEN ACCOMPANIED BY MILD NAUSEA.
USE OF AN OTC H2 ANTAGONIST AFFORDS PARTIAL SYMPTOM RELIEF. SHE ALSO USES DICLOFENAC
ON A REGULAR BASIS FOR THE CONTROL OF OA PAIN. HER CLINICAL PRESENTATION IS LIKELY:
• ACUTE GASTROENTERITIS
• GASTRIC ULCER
• DUODENAL ULCER
• CHRONIC CHOLECYSTITIS
A23
• A 64 YEAR OLD FEMALE PRESENTS WITH A 3 MONTH HISTORY OF UPPER ABDOMINAL PAIN. SHE
DESCRIBES THE DISCOMFORT AS AN INTERMITTENT, CENTRALLY LOCATED “BURNING” FEELING IN
THE UPPER ABDOMEN, MOST OFTEN WITH MEALS AND OFTEN ACCOMPANIED BY MILD NAUSEA.
USE OF AN OTC H2 ANTAGONIST AFFORDS PARTIAL SYMPTOM RELIEF. SHE ALSO USES DICLOFENAC
ON A REGULAR BASIS FOR THE CONTROL OF OA PAIN. HER CLINICAL PRESENTATION IS LIKELY:
• ACUTE GASTROENTERITIS
• GASTRIC ULCER
• DUODENAL ULCER
• CHRONIC CHOLECYSTITIS
Q24
• IN CARING FOR A PATIENT WITH SYMPTOMATIC GERD, YOU PRESCRIBE A PPI TO:
• ENHANCE MOTILITY
• INCREASE THE PH OF THE STOMACH
• REDUCE LOWER ESOPHAGEAL PRESSURE
• HELP LIMIT H PYLORI
A24
• IN CARING FOR A PATIENT WITH SYMPTOMATIC GERD, YOU PRESCRIBE A PPI TO:
• ENHANCE MOTILITY
• INCREASE THE PH OF THE STOMACH
• REDUCE LOWER ESOPHAGEAL PRESSURE
• HELP LIMIT H PYLORI
Q25
• WHICH OF THE FOLLOWING IS NOT AN ALARM FINDING IN GERD?
• WEIGHT GAIN
• DYSPHAGIA
• ODYNOPHAGIA
• IDA
A25
• WHICH OF THE FOLLOWING IS NOT AN ALARM FINDING IN GERD?
• WEIGHT GAIN
• DYSPHAGIA
• ODYNOPHAGIA
• IDA
Q26
• A 57 YEAR OLD MALE NEEDS AN EVALUATION FOR BARRETT ESOPHAGUS. YOU RECOMMEND:
• H PYLORI TESTING
• CT SCAN
• UPPER GI ENDOSCOPY WITH BIOPSY
• BARIUM SWALLOW
A26
• A 57 YEAR OLD MALE NEEDS AN EVALUATION FOR BARRETT ESOPHAGUS. YOU RECOMMEND:
• H PYLORI TESTING
• CT SCAN
• UPPER GI ENDOSCOPY WITH BIOPSY
• BARIUM SWALLOW
Q27
• A SEROLOGICAL MARKER FOR ACUT HEPATITIS A INFECTION IS
• HAV IGM
• HAV VIRAL RNA
• TNFA
• IL-10
A27
• A SEROLOGICAL MARKER FOR ACUT HEPATITIS A INFECTION IS
• HAV IGM
• HAV VIRAL RNA
• TNFA
• IL-10
Q28
• A PATIENT HAS THE FOLLOWING LAB RESULTS: HBSAG NEGATIVE; ANTI-HBC NEGATIVE; ANTI
HBS POSITIVE. WHAT DOES THIS INDICATE?
• NO INFECTION, NO IMMUNITY
• IMMUNE DUE TO NATURAL INFECTION
• IMMUNE DUE TO IMMUNIZATION
• ACUTELY INFECTED
A28
• A PATIENT HAS THE FOLLOWING LAB RESULTS: HBSAG NEGATIVE; ANTI-HBC NEGATIVE; ANTI
HBS POSITIVE. WHAT DOES THIS INDICATE?
• NO INFECTION, NO IMMUNITY
• IMMUNE DUE TO NATURAL INFECTION
• IMMUNE DUE TO IMMUNIZATION
• ACUTELY INFECTED
Q29
• WHICH OF THE FOLLOWING PATIENT COMPLAINTS SHOULD BE EVALUATED FURTHER WHEN
MAKING THE DIFFERENTIAL DIAGNOSIS OF IBS?
• HISTORY OF COLORECTAL CANCER, RECENT CONSTIPATION AND ABDOMINAL PAIN
• MIDDLE ADULT WITH LOW ALBUMIN AND LEUKOCYTOSIS
• BOTH PATENTS OUTLINED ABOVE
• A 16 YEAR OLD WITH CHRONIC, ALTERNATING CONSTIPATION AND DIARRHEA WHEN SHE IS
STUDYING FOR HIGH SCHOOL EXAMS AND WORRYING ABOUT HER PARENTS’ IMPENDING MOVE
A29
• WHICH OF THE FOLLOWING PATIENT COMPLAINTS SHOULD BE EVALUATED FURTHER WHEN
MAKING THE DIFFERENTIAL DIAGNOSIS OF IBS?
• HISTORY OF COLORECTAL CANCER, RECENT CONSTIPATION AND ABDOMINAL PAIN
• MIDDLE ADULT WITH LOW ALBUMIN AND LEUKOCYTOSIS
• BOTH PATENTS OUTLINED ABOVE
• A 16 YEAR OLD WITH CHRONIC, ALTERNATING CONSTIPATION AND DIARRHEA WHEN SHE IS
STUDYING FOR HIGH SCHOOL EXAMS AND WORRYING ABOUT HER PARENTS’ IMPENDING MOVE
Q30
• LAB RESULTS DURING AN IBD FLARE WILL REVEAL ELEVATED LEVELS OF ALL OF THE
FOLLOWING EXCEPT?
• CRP
• SECR
• ESR
• WBC
A 30
• LAB RESULTS DURING AN IBD FLARE WILL REVEAL ELEVATED LEVELS OF ALL OF THE
FOLLOWING EXCEPT?
• CRP
• SECR
• ESR
• WBC
Q31
• “SKIP LESIONS” ARE USUALLY REPORTED DURING COLONOSCOPY IN:
• IBS
• ULCERATIVE COLITIS
• CHRON’S DISEASE
• C DIFFICILE COLITIS
A31
• “SKIP LESIONS” ARE USUALLY REPORTED DURING COLONOSCOPY IN:
• IBS
• ULCERATIVE COLITIS
• CHRON’S DISEASE
• C DIFFICILE COLITIS
Q32
• CHRON’S DISEASE IS ASSOCIATED WITH INCREASED RISK OF MALIGNANCY INVOLVING THE
• SMALL BOWEL
• LARGE INTESTINE
• DUODENUM
• STOMACH
A32
• CHRON’S DISEASE IS ASSOCIATED WITH INCREASED RISK OF MALIGNANCY INVOLVING THE
• SMALL BOWEL
• LARGE INTESTINE
• DUODENUM
• STOMACH
Q33
• THE MOST ACCURATE SEROLOGICAL MARKERS TO DIAGNOSE CELIAC SPRUE ARE:
• ESR AND CRP
• IGA ENDOMYSIAL AND IGA TTG ANTIBODIES
• MUCOSAL BIOPSIES OF THE TERMINAL ILEUM
• H PYLORI IGG ANTIBODIES
A33
• THE MOST ACCURATE SEROLOGICAL MARKERS TO DIAGNOSE CELIAC SPRUE ARE:
• ESR AND CRP
• IGA ENDOMYSIAL AND IGA TTG ANTIBODIES
• MUCOSAL BIOPSIES OF THE TERMINAL ILEUM
• H PYLORI IGG ANTIBODIES